German Coronavirus Vaccine Developer CureVac Denies US Bid

FRANKFURT, GERMANY - CureVac, the German biotech firm at the center of an argument over alleged U.S. attempts to gain access to an experimental coronavirus vaccine it is developing, denied Tuesday